MYX 2.11% $4.17 mayne pharma group limited

Ann: Preliminary Final Report, page-20

  1. 199 Posts.
    lightbulb Created with Sketch. 4
    Increased revenue of 114%
    Underlying EBITDA up 133%
    Net profit after tax was up 137%

    Those are STRONG numbers and growth in any sector by any stretch of the imagination.

    Hahaha I love how shorting commenters on here are focused on dubious outlooks, inconsequential DOJ investigation and being outlandishly bearish despite the figures.

    As a value investor I am not worried. If his trajectory continues we'll be laughing in 2-3 years time.

    It's a day of celebration. Let day traders and shorters come, they'll die with the weight true value of the company.
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.